Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA] - N0000193914

Pharmacologic Class Information

Pharmacologic Code N0000193914
Pharmacologic Name Adenosine Triphosphate-Citrate Lyase Inhibitors
Pharmacologic Uses
  • adenosine triphosphate-citrate lyase (ACL) inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Adenosine Triphosphate-Citrate Lyase Inhibitors

The following table contains 2 products whose active ingredient are classified under the same pharmacologic class Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
72426-118Nexletol Non-Proprietary Name: Bempedoic AcidTablet, Film CoatedOralEsperion Therapeutics, Inc.ACTIVE
72426-818Nexlizet Non-Proprietary Name: Bempedoic Acid And EzetimibeTablet, Film CoatedOralEsperion Therapeutics, Inc.ACTIVE